Urine Metabolites in the Diagnosis of Disease

Description

The goal of this observational study is to validate a non-invasive, urine-based diagnostic technology for the detection and differentiation of various gastrointestinal (GI) diseases. This research study intends to enroll participants across a range of demographics and GI disease states including colorectal cancer, small intestinal bacterial overgrowth (SIBO), Crohn\'s disease, and Celiac disease, collect urine samples and clinical data, and use artificial intelligence and machine learning to build disease-specific models which can identify and differentiate a participants' specific GI disease. The main questions it aims to answer are: 1. Does the platform identify a disease signal within each disease cohort, compared to normal controls? 2. How well does the test perform (e.g. sensitivity and specificity/false-positive rate)?

Conditions

Colorectal Cancer, Small Intestinal Bacterial Overgrowth Syndrome (SIBO), Crohn Disease, Celiac Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this observational study is to validate a non-invasive, urine-based diagnostic technology for the detection and differentiation of various gastrointestinal (GI) diseases. This research study intends to enroll participants across a range of demographics and GI disease states including colorectal cancer, small intestinal bacterial overgrowth (SIBO), Crohn\'s disease, and Celiac disease, collect urine samples and clinical data, and use artificial intelligence and machine learning to build disease-specific models which can identify and differentiate a participants' specific GI disease. The main questions it aims to answer are: 1. Does the platform identify a disease signal within each disease cohort, compared to normal controls? 2. How well does the test perform (e.g. sensitivity and specificity/false-positive rate)?

Observational Study of Urine Metabolites in the Diagnosis of Disease

Urine Metabolites in the Diagnosis of Disease

Condition
Colorectal Cancer
Intervention / Treatment

-

Contacts and Locations

Encinitas

Unio Health Partners (Gastroenterology), Encinitas, California, United States, 92024

Walnut Creek

Bass Medical Group (Gastroenterology), Walnut Creek, California, United States, 94598

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥ 18 years of age at time of enrollment.
  • * Able and willing to provide a one-time urine sample and comply with all study procedures for the study.
  • * Able to understand the study procedures, able to provide consent to participate in the study, and willing to authorize release of relevant protected health information by consenting to a HIPAA medical release form.
  • * Known to be pregnant.
  • * A medical condition which, in the opinion of the Investigator and/or Sponsor, should preclude enrollment in the study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Luventix, Inc.,

John Spinosa, MD, PhD, PRINCIPAL_INVESTIGATOR, Luventix, Inc.

Study Record Dates

2026-09